The role of high-dose cytarabine as consolidation therapy before allogeneic hematopoietic cell transplantation for acute myeloid leukaemia without core-binding factor in the first complete remission

被引：0

作者：

Lee, Yoo Jin ^{[1
]}

Sohn, Sang Kyun ^{[1
]}

Moon, Joon Ho ^{[1
]}

Kim, Hyeoung-Joon ^{[2
]}

Ahn, Jae Sook ^{[2
]}

Ahn, Seo-Yeon ^{[2
]}

Do, Young Rok ^{[3
]}

Lee, Ji Hyun ^{[4
]}

机构：

[1] Kyungpook Natl Univ Hosp, Daegu, South Korea

[2] Chonnam Natl Univ, Hwasun Hosp, Hwasun, Jeollanamdo, South Korea

[3] Keimyung Univ, Dongsan Med Ctr, Daegu, South Korea

[4] Dong A Med Ctr, Pusan, South Korea

来源：

BONE MARROW TRANSPLANTATION | 2018年 / 53卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P060

引用

页码：191 / 192

页数：2

共 50 条

[31] History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease-negative first complete remission
Rashidi, Armin
Linden, Michael A.
DeFor, Todd E.
Warlick, Erica
Bejanyan, Nelli
Yohe, Sophia
Weisdorf, Daniel J.
Ustun, Celalettin
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) : 1032 - 1036
[32] A randomized trial of high- versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine
Bradstock, KF
Matthews, JP
Lowenthal, RM
Baxter, H
Catalano, J
Brighton, T
Gill, D
Eliadis, P
Joshua, D
Cannell, P
Schwarer, AP
Durrant, S
Gillett, A
Koutts, J
Taylor, K
Bashford, J
Arthur, C
Enno, A
Dunlop, L
Szer, J
Leahy, M
Juneja, S
Young, GAR
BLOOD, 2005, 105 (02) : 481 - 488
[33] Frequency of Allogeneic Hematopoietic Cell Transplantation Among Patients With High- or Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission
Mawad, Raya
Gooley, Ted A.
Sandhu, Vicky
Lionberger, Jack
Scott, Bart
Sandmaier, Brenda M.
O'Donnell, Paul
Becker, Pamela S.
Petersdorf, Stephen
Dorcy, Kathleen Shannon
Hendrie, Paul
Sorror, Mohamed L.
Walter, Roland B.
Deeg, H. Joachim
Appelbaum, Frederick R.
Estey, Elihu H.
Pagel, John M.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31) : 3883 - +
[34] Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission
Konuma, Takaaki
Kondo, Tadakazu
Masuko, Masayoshi
Shimizu, Hiroaki
Shiratori, Souichi
Fukuda, Takahiro
Kato, Jun
Sawa, Masashi
Ozawa, Yukiyasu
Ota, Shuichi
Uchida, Naoyuki
Kanda, Yoshinobu
Kako, Shinichi
Fujisawa, Shin
Fukushima, Kentaro
Ichinohe, Tatsuo
Atsuta, Yoshiko
Yanada, Masamitsu
BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2779 - 2787
[35] Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission
Takaaki Konuma
Tadakazu Kondo
Masayoshi Masuko
Hiroaki Shimizu
Souichi Shiratori
Takahiro Fukuda
Jun Kato
Masashi Sawa
Yukiyasu Ozawa
Shuichi Ota
Naoyuki Uchida
Yoshinobu Kanda
Shinichi Kako
Shin Fujisawa
Kentaro Fukushima
Tatsuo Ichinohe
Yoshiko Atsuta
Masamitsu Yanada
Bone Marrow Transplantation, 2021, 56 : 2779 - 2787
[36] Allogeneic bone marrow transplantation compared with autologous peripheral blood stem cell transplantation in patients with acute myeloid leukaemia in first complete remission
Jimenez, M
Espigares, A
Santiago, J
Fernandez, C
Capote, M
Martin, C
Herrera, C
Casaño, J
Torres, A
BONE MARROW TRANSPLANTATION, 2004, 33 : S233 - S234
[37] Effect of Postremission Therapy before Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia in First Complete Remission
Warlick, Erica D.
Paulson, Kristjan
Brazauskas, Ruta
Zhong, Xiaobo
Miller, Alan M.
Camitta, Bruce M.
George, Biju
Savani, Bipin N.
Ustun, Celalettin
Marks, David I.
Waller, Edmund K.
Baron, Frederic
Freytes, Cesar O.
Socie, Gerard
Akpek, Gorgun
Schouten, Harry C.
Lazarus, Hillard M.
Horwitz, Edwin M.
Koreth, John
Cahn, Jean-Yves
Bornhauser, Martin
Seftel, Matthew
Cairo, Mitchell S.
Laughlin, Mary. J.
Sabloff, Mitchell
Ringden, Olle
Gale, Robert Peter
Kamble, Rammurti T.
Vij, Ravi
Gergis, Usama
Mathews, Vikram
Saber, Wael
Chen, Yi-Bin
Liesveld, Jane L.
Cutler, Corey S.
Ghobadi, Armin
Uy, Geoffrey L.
Eapen, Mary
Weisdorf, Daniel J.
Litzow, Mark R.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : 202 - 208
[38] Treatment of Therapy-Related Myeloid Neoplasms with High-Dose Cytarabine/Mitoxantrone Followed by Hematopoietic Cell Transplantation (HCT).
Godley, Lucy A.
Njiaju, Uchenna O.
Green, Margaret
Weiner, Howard
Lin, Shang
Odenike, Olatoyosi
Rich, Elizabeth Shima
Artz, Andrew
van Besien, Koen
Daugherty, Christopher
Zhang, Yanming
Le Beau, Michelle M.
Stock, Wendy
Larson, Richard A.
BLOOD, 2009, 114 (22) : 426 - 426
[39] A second course of high-dose cytarabine before autologous stem cell transplantation does not improve outcome of young acute myeloid leukemia patients in first complete remission: Results of the BGMT 95 study.
Jourdan, E
Riga-Huguet, F
Marit, G
Vey, N
Dastugue, N
Fegueux, N
Molina, L
Gastaut, JA
Legros, L
Zerazhi, H
Cailleres, S
Bauduer, F
Bordessoule, D
Attal, M
Blaise, D
Pigneux, A
BLOOD, 2004, 104 (11) : 383B - 383B
[40] Allogeneic hematopoietic stem cell transplantation versus intensive chemotherapy in intermediate risk acute myeloid leukemia in first complete remission
Furlanetto, M.
Paz, A.
Rigoni, L.
Fischer, G.
Michalowski, M.
Daudt, L. E.
Silla, L.
BONE MARROW TRANSPLANTATION, 2016, 51 : S285 - S285

← 1 2 3 4 5 →